Galloway JB - Search Results

1

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.

Bechman K, Dalrymple A, Southey-Bassols C, Cope AP, Galloway JB. Bechman K, et al. Among authors: galloway jb. BMC Rheumatol. 2020 Nov 2;4(1):70. doi: 10.1186/s41927-020-00154-3. BMC Rheumatol. 2020. PMID: 33292827 Free PMC article.

2

The ying and yang of fever in rheumatic disease.

Galloway J, Cope AP. Galloway J, et al. Clin Med (Lond). 2015 Jun;15(3):288-91. doi: 10.7861/clinmedicine.15-3-288. Clin Med (Lond). 2015. PMID: 26031982 Free PMC article.

3

Is there a role of synovial biopsy in drug development?

Filkova M, Cope A, Mant T, Galloway J. Filkova M, et al. BMC Musculoskelet Disord. 2016 Apr 19;17:172. doi: 10.1186/s12891-016-1028-5. BMC Musculoskelet Disord. 2016. PMID: 27094362 Free PMC article. Review.

4

Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.

Filkova M, Carvalho J, Norton S, Scott D, Mant T, Molokhia M, Cope A, Galloway J. Filkova M, et al. J Rheumatol. 2017 Dec;44(12):1786-1793. doi: 10.3899/jrheum.160818. Epub 2017 Oct 1. J Rheumatol. 2017. PMID: 28966210

5

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

Ibrahim F, Lorente-Cánovas B, Doré CJ, Bosworth A, Ma MH, Galloway JB, Cope AP, Pande I, Walker D, Scott DL. Ibrahim F, et al. Among authors: galloway jb. Rheumatology (Oxford). 2017 Nov 1;56(11):2004-2014. doi: 10.1093/rheumatology/kex315. Rheumatology (Oxford). 2017. PMID: 28968858 Free PMC article. Clinical Trial.

6

A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.

Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB. Subesinghe S, et al. Among authors: galloway jb. J Rheumatol. 2018 Jun;45(6):733-744. doi: 10.3899/jrheum.170710. Epub 2018 Mar 15. J Rheumatol. 2018. PMID: 29545454

7

Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.

Bechman K, Tweehuysen L, Garrood T, Scott DL, Cope AP, Galloway JB, Ma MHY. Bechman K, et al. Among authors: galloway jb. J Rheumatol. 2018 Nov;45(11):1515-1521. doi: 10.3899/jrheum.171375. Epub 2018 Sep 1. J Rheumatol. 2018. PMID: 30173149 Free PMC article.

8

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.

Gullick NJ, Ibrahim F, Scott IC, Vincent A, Cope AP, Garrood T, Panayi GS, Scott DL, Kirkham BW; TITRATE Programme Investigators. Gullick NJ, et al. BMC Rheumatol. 2019 Feb 25;3:6. doi: 10.1186/s41927-019-0054-y. eCollection 2019. BMC Rheumatol. 2019. PMID: 30886994 Free PMC article.

9

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.

Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, Winthrop KL, Galloway JB. Bechman K, et al. Among authors: galloway jb. Rheumatology (Oxford). 2019 Oct 1;58(10):1755-1766. doi: 10.1093/rheumatology/kez087. Rheumatology (Oxford). 2019. PMID: 30982883

10

Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Bechman K, Clarke BD, Rutherford AI, Yates M, Nikiphorou E, Molokhia M, Norton S, Cope AP, Hyrich KL, Galloway JB. Bechman K, et al. Among authors: galloway jb. Rheumatology (Oxford). 2019 Oct 1;58(10):1767-1776. doi: 10.1093/rheumatology/kez037. Rheumatology (Oxford). 2019. PMID: 30982886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page